Aldeyra Therapeutics, Inc. (ALDX)
0.6943
+0.02
(+3.69%)
USD |
NASDAQ |
Nov 17, 14:15
Aldeyra Therapeutics Total Return Level : 0.6696 for Nov. 16, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 16, 2026 | 0.6696 |
| November 13, 2026 | 0.6438 |
| November 12, 2026 | 0.6301 |
| November 11, 2026 | 0.6514 |
| November 10, 2026 | 0.6291 |
| November 09, 2026 | 0.636 |
| November 06, 2026 | 0.6337 |
| November 05, 2026 | 0.6159 |
| November 04, 2026 | 0.6474 |
| November 03, 2026 | 0.6206 |
| November 02, 2026 | 0.5832 |
| October 30, 2026 | 0.5603 |
| October 29, 2026 | 0.6591 |
| October 28, 2026 | 0.6836 |
| October 27, 2026 | 0.6412 |
| October 26, 2026 | 0.6417 |
| October 23, 2026 | 0.6497 |
| October 22, 2026 | 0.6453 |
| October 21, 2026 | 0.6703 |
| October 20, 2026 | 0.7343 |
| October 19, 2026 | 0.6651 |
| October 16, 2026 | 0.7001 |
| October 15, 2026 | 0.7373 |
| October 14, 2026 | 0.7904 |
| October 13, 2026 | 0.8998 |
| Date | Value |
|---|---|
| October 12, 2026 | 0.9058 |
| October 09, 2026 | 0.9163 |
| October 08, 2026 | 0.9477 |
| October 07, 2026 | 0.9586 |
| October 06, 2026 | 0.9159 |
| October 05, 2026 | 0.9237 |
| October 02, 2026 | 1.17 |
| October 01, 2026 | 1.29 |
| September 30, 2026 | 1.23 |
| September 29, 2026 | 1.32 |
| September 28, 2026 | 1.16 |
| September 25, 2026 | 1.205 |
| September 24, 2026 | 1.22 |
| September 23, 2026 | 1.35 |
| September 22, 2026 | 1.395 |
| September 21, 2026 | 1.35 |
| September 18, 2026 | 1.36 |
| September 17, 2026 | 1.38 |
| September 16, 2026 | 1.37 |
| September 15, 2026 | 1.37 |
| September 14, 2026 | 1.46 |
| September 11, 2026 | 1.34 |
| September 10, 2026 | 1.46 |
| September 09, 2026 | 1.50 |
| September 08, 2026 | 1.54 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Prime Medicine, Inc. | 4.19 |
| Oncolytics Biotech, Inc. | 0.3399 |
| Sangamo Therapeutics, Inc. | 0.1089 |
| Sarepta Therapeutics, Inc. | 15.13 |
| Anixa Biosciences, Inc. | 2.55 |